Lifileucel:

Simran Deep Kaur1, Md Abubakar2, Neena Bedi3

  • 1School of Pharmaceutical Sciences, Shoolini University of Biotechnology and Management Sciences, Solan 173229, India.

Current problems in cancer
|September 13, 2025
PubMed
概括

瘤透淋巴细胞 (TIL) 疗法Lifileucel为晚期癌症患者提供了新的希望. 这种细胞疗法利用TIL向瘤,在临床试验中显示出有希望的生存益处.